DBV Technologies | 当期純利益



Net Income 変化する 日付
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
Alnylam Pharmaceuticals USD -83763000 27.81M 2024-12
Amarin USD -25134000 26.66M 2024-09
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
DBV Technologies USD -30442000 2.67M 2024-09
Halozyme Therapeutics USD 137.01M 1000 2024-12
Incyte USD 201.21M 94.76M 2024-12
Insmed USD -235548000 15.02M 2024-12
Ionis Pharmaceuticals USD -104349000 36.13M 2024-12
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
PTC Therapeutics USD -65886000 40.77M 2024-12
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
Ultragenyx Pharmaceutical USD -133385000 131K 2024-12
United Therapeutics USD 301.3M 7.8M 2024-12



DBV Technologies 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Mar 2025.